Tritace
developed to manage high blood pressure and to support heart health by inhibiting the angiotensin-converting enzyme.
Strengths: 1.25 · 2.5 · 5 · 10mg
Where to Check Availability
Medicine details
- Alternative names
Ramcace
- Therapeutic class
ACE Inhibitor
- Pharmacological class
Angiotensin-Converting Enzyme Inhibitor
- Contraindications
history of angioedema; bilateral renal artery stenosis; pregnancy
- Minor side effects
dry cough; dizziness; headache
- Moderate side effects
fatigue; hypotension; nausea
- Dosage forms
Tablet
- Administration route
Oral use
- Prescription status
POM
- Manufacturer
Sanofi
- Onset Time
1–2 hours
- Duration
24 hours
- Storage instructions
Store below 25°C in a dry place.
- Drug interactions
potassium supplements; diuretics; ibuprofen
- Age restrictions
Not recommended for use in children.
Precautions and warnings
be aware of initial dizziness; regularly monitor blood pressure and kidney function; report any persistent dry cough
Serious side effects
angioedema — requires immediate medical attention; renal failure — requires immediate medical attention; severe hypotension — requires immediate medical attention
Patient summary
developed to manage high blood pressure and to support heart health by inhibiting the angiotensin-converting enzyme.
Mechanism of action
Tritace operates by inhibiting the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor. By reducing angiotensin II levels, it relaxes blood vessels and lowers blood pressure while reducing the workload on the heart.
Pregnancy and breastfeeding
Contraindicated during pregnancy as it may cause fetal harm. Breastfeeding: Not recommended.
Tritace
developed to manage high blood pressure and to support heart health by inhibiting the angiotensin-converting enzyme.
Editorial Notes
- Active ingredient(s): Ramipril
- Listed indication(s): Hypertension, Congestive Heart Failure, Post-myocardial Infarction
Usually available as
- 180 tablets - 1.25 mg298-1-25-mg-1763
- 90 tablets - 2.5 mg298-2-5-mg-1756
- 60 tablets - 5 mg298-5-mg-1765